Connect with us

Health

Judd Moul, MD, Reviews Studies From 2021 ASCO Showing Systemic Therapy Advancements in Prostate Cancer – Cancer Network

Judd Moul, MD, discusses the gravity of new data on systemic therapies for men with castration-resistant prostate cancer and…

Published

on

Article feature image
ADVERTISEMENT

Both trials demonstrated benefit of the experimental therapy in their respective patient cohorts, helping prolong overall survival versus standard-of-care regimens.
In an interview with CancerNetwork®, Judd Moul, MD, discussed these findings from the meeting…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending